📰 Ptom Keith Roach News
Page 2 - Ptom Keith Roach News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Ptom Keith Roach. Real-time updates on events, politics, business and more.
April 6, 2023
INNOVATIVE ACCESS DEAL SECURED IN THE UK FOR LYNPARZA (OLAPARIB) TO TREAT BRCA-MUTATED CANCERS Olaparib is the first and only treatment available within NHS England for patients with germline BRCA mutations in early breast cancer (stage I-IIIA) and patients with metastatic castration-resistant prostate cancer (...
September 7, 2022
STRICTLY EMBARGOED UNTIL Tuesday 6 September 2022 00:01 BST LYNPARZA (olaparib) APPROVED IN GREAT BRITAIN AS ADJUVANT TREATMENT FOR PATIENTS WITH GERMLINE BRCA-MUTATED HER2-NEGATIVE HIGH-RISK EARLY BREAST CANCER First and only approved medicine in Great Britain which targets germline BRCA mutations in pati...
March 19, 2022
Approval is significant as waning restrictions present significant threats to many immunocompromised people across the UK - News - PharmaTimes
January 26, 2022
NICE EXPANDS GUIDANCE FOR LOKELMA®▼(sodium zirconium cyclosilicate) IN ADULT PATIENTS WITH PERSISTENT HYPERKALAEMIA People living with persistent hyperkalaemia in England, Wales and Northern Ireland will now be able to access repeat prescriptions of sodium zirconium cyclosilicate (SZC) in the community.[1]T...
January 25, 2022
NICE EXPANDS GUIDANCE FOR LOKELMA®▼(sodium zirconium cyclosilicate) IN ADULT PATIENTS WITH PERSISTENT HYPERKALAEMIA People living with persistent hyperkalaemia in England, Wales and Northern Ireland will now be able to access repeat prescriptions of sodium zirconium cyclosilicate (SZC) in the community.[1]T...
December 30, 2021
Vaccination programme has been a phenomenal success, saving countless lives and reducing pressure on NHS 2.5 billion doses of the at-cost and UK-made
December 30, 2021
A year ago today, the UK became the first country in the world to approve the Oxford University/AstraZeneca vaccine.
December 30, 2021
Boris Johnson has praised the Oxford/AstraZeneca vaccine for saving many millions of lives as the UK marks becoming the first country to approve the COVID vaccine exactly one year ago.
December 15, 2021
The voluntary withdrawal of the type 1 diabetes indication for dapagliflozin in the EU by AstraZeneca has been branded as appalling and devastating, with questions raised as to why it was pulled.
November 30, 2021
Osimertinib will be made available via the Cancer Drugs Fund (CDF) to patients in England with completely resected early-stage IB-IIIA EGFR mutation-positive (EGFRm) non-small cell lung cancer (NSCLC).1